Related content

A Phase II Trial of Isolated Limb Infusion With Melphalan and Dactinomycin for Regional Melanoma and Soft Tissue Sarcoma of the Extremity

By Brady Mary   Brown Karen   Patel Ami   Fisher Charles   Marx Will  

Annals of Surgical Oncology, Vol. 13, Iss. 8, 2006-08 ,pp. : 1123-1129

Springer Publishing Company

Access to resources Recommend Favorite

Advanced Extremity Soft Tissue Sarcoma: Prognostic Effect of Isolated Limb Perfusion in a Series of 88 Patients Treated at a Single Institution

By Pennacchioli Elisabetta   Deraco Marcello   Mariani Luigi   Fiore Marco   Mussi Chiara   Collini Paola   Olmi Patrizia   Casali Paolo   Santinami Mario   Gronchi Alessandro  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 553-559

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Locoregional Vascular Morbidity After Isolated Limb Perfusion and External-Beam Radiotherapy for Soft Tissue Sarcoma of the Extremity

By Hoven-Gondrie Miriam   Thijssens Katja   Dungen Jan   Loonstra Jan   Ginkel Robert   Hoekstra Harald  

Annals of Surgical Oncology, Vol. 14, Iss. 7, 2007-07 ,pp. : 2105-2112

Springer Publishing Company

Access to resources Recommend Favorite

Isolated Limb Perfusion With Melphalan and Tumor Necrosis Factor α for Advanced Melanoma and Soft-Tissue Sarcoma

By Hayes Andrew   Neuhaus Susan   Clark Matthew   Thomas J.  

Annals of Surgical Oncology, Vol. 14, Iss. 1, 2007-01 ,pp. : 230-238

Springer Publishing Company

Access to resources Recommend Favorite

Impact of hyperthermic isolated limb perfusion on tumour oxygenation in soft tissue sarcoma

By Jakob Jens   von Rege Inez   Weiss Christel   Hohenberger Peter  

International Journal of Hyperthermia, Vol. 28, Iss. 7, 2012-11 ,pp. : 591-596

Informa Healthcare

Access to resources Recommend Favorite